Αποτελέσματα Αναζήτησης
Revolutionary infusion pump technology based on pneumatics rather than mechanics with huge safety / clinical / economic benefits for payors, providers, patients. Cardinal Partners is founding investor providing regulatory planning, investor syndicate and strategic partnering.
- Team
The operating and investment backgrounds of the Cardinal’s...
- Companies
Revolutionary infusion pump technology based on pneumatics...
- Our Vision
The transition from paper to digital combined with machine...
- Contact
Princeton Office (HQ) 230 Nassau Street, Princeton, NJ 08542...
- Venture Partners
Venture Partners; Venture Partners Together we can achieve...
- John Clarke
John currently serves on the Board of Directors for Cardinal...
- Thomas Mckinley
Thomas McKinley has over 35 years of venture capital...
- Events
© 2019 Cardinal Partners. All rights reserved. Scroll to top
- Team
Founded in 1996, Cardinal Partners is a venture capital firm based in Princeton, New Jersey. The firm prefers to invest in the healthcare, consumer, machine learning, blockchain, technology, and life sciences sectors.
Revolutionary infusion pump technology based on pneumatics rather than mechanics with huge safety / clinical / economic benefits for payors, providers, patients. Cardinal Partners is founding investor providing regulatory planning, investor syndicate and strategic partnering.
29 Οκτ 2024 · Cardinal Partners - Life science & tech focused VC firm investing in early stage companies in the US. Portfolio of 35 companies. 66 investors have invested with Cardinal Partners. Team has 10 members.
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Cardinal Partners is a venture capital firm focused exclusively on healthcare investing.
Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies | Cardinal Partners has extensive experience in starting, incubating and...
John currently serves on the Board of Directors for Cardinal portfolio companies Abide Therapeutics, aTyr Pharma, Ivenix , and Vividion Therapeutics, as well as Alnylam Pharmaceuticals. John entered the venture industry in 1982 with DSV Partners, a pioneer venture capital fund formed in 1968.
